Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Nanochitins, especially DNCh and PNCh, effectively promote hair growth.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

UC.145 may be a new biomarker for predicting gastric cancer.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Low CD4 counts in HIV patients are linked to more skin disorders.